Fosaprepitant Dimeglumine | CAS 265121-04-8 | NK1 Receptor Antagonist Prodrug for Neurokinin Pathway Research

Sale

Fosaprepitant Dimeglumine | CAS 265121-04-8 | NK1 Receptor Antagonist Prodrug for Neurokinin Pathway Research

Original price was: $3.00.Current price is: $2.00.

Fosaprepitant Dimeglumine (CAS 265121-04-8) is a high-purity lyophilized powder supplied for preclinical research. It serves as a phosphorylated prodrug of aprepitant, used to investigate NK1 receptor signaling, neurokinin-1 pathway modulation, cytokine regulation, and cellular stress responses in molecular, cellular, and pharmacological studies.

EMI starting from $0.00/month - View Plans

Description

Product Description

Fosaprepitant Dimeglumine (CAS 265121-04-8) is a phosphorylated prodrug of aprepitant extensively used in preclinical research to investigate NK1 receptor-mediated signaling, neurokinin pathways, and cytokine modulation. Fosaprepitant Dimeglumine’s lyophilized powder form provides enhanced solubility, precise dosing, and reproducibility in both in vitro and in vivo assays.

Pharmacological Background

The NK1 receptor is a G-protein-coupled receptor (GPCR) expressed in central and peripheral nervous systems, immune cells, and epithelial tissues. Its primary endogenous ligand, Substance P, mediates neurogenic inflammation, neurotransmission, and immune modulation. Fosaprepitant Dimeglumine, once enzymatically dephosphorylated, converts to aprepitant, a selective NK1 receptor antagonist, making it a reliable tool to study receptor desensitization, ligand binding kinetics, and downstream MAPK/ERK, JNK, and p38 signaling pathways.

Fosaprepitant Dimeglumine is widely used to explore:

  • Neuroimmune interactions and cytokine modulation (IL-1β, IL-6, TNF-α)

  • Central and peripheral nervous system stress responses

  • GPCR-mediated intracellular calcium signaling

  • MAPK/ERK, JNK, and p38 signal transduction

  • Receptor internalization and desensitization

  • Neuroinflammatory and oxidative stress models

Research Applications

Fosaprepitant Dimeglumine is applied in molecular, cellular, and pharmacological studies. Its prodrug design enhances solubility and experimental handling while preserving pharmacological activity. Key applications include:

  • NK1 receptor pathway blockade and desensitization studies

  • Cytokine secretion and immune modulation assays

  • Neuroinflammatory model studies in vitro and in vivo

  • Ligand-receptor binding kinetics and pharmacodynamic studies

  • Oxidative stress and signaling pathway modulation

  • Preclinical pharmacokinetic and pharmacodynamic evaluations

The lyophilized powder format allows reconstitution in water or appropriate laboratory-grade buffers, enabling concentrations typically ranging from 1 to 50 mg/mL. Fosaprepitant Dimeglumine facilitates controlled and reproducible experimental conditions, providing a reliable platform for high-quality preclinical research.

Fosaprepitant Dimeglumine is also extensively used in combination studies to explore synergistic or antagonistic effects with other signaling modulators, kinase inhibitors, or neuroactive compounds. Its reproducibility and stability in lyophilized form make it a preferred choice for laboratories conducting comprehensive NK1 receptor research.

Fosaprepitant Dimeglumine
Fosaprepitant Dimeglumine

Product Specifications

ParameterSpecification / Data
Chemical Name / SynonymsFosaprepitant Dimeglumine; Fosaprepitant Meglumine; Prodrug of Aprepitant; C23H22F7N4O6P·2(C7H17NO5)
CAS Number265121-04-8
Molecular FormulaC23H22F7N4O6P·2(C7H17NO5)
Molecular Weight1004.0 g/mol
Purity / Assay≥99%
AppearanceWhite to off-white lyophilized powder
Dosage FormLyophilized powder for research use
SolubilityWater, DMSO, selected aqueous buffers
ConcentrationReconstitutable to 1–50 mg/mL depending on assay
Storage Temperature2–8 °C, protect from moisture and light
StabilityHighly stable lyophilized; avoid repeated freeze–thaw cycles
Analytical MethodsHPLC, MS, NMR verified; batch consistency confirmed
Mechanistic TargetNK1 receptor antagonist (via conversion to aprepitant)
Structural CategoryNK1 receptor antagonist prodrug; phosphorylated small molecule
ApplicationsNK1 receptor studies, cytokine modulation, neuroimmune signaling, GPCR biology, receptor-ligand kinetics, in vivo pharmacology
Batch ConsistencyVerified by HPLC, MS, NMR analyses
Regulatory NotesFor laboratory research use only
OriginFactory small-molecule supplier; China chemical manufacturer; OEM & bulk production available
Additional DataCoA provided for each batch

Mechanism of Action

Prodrug Activation

Fosaprepitant Dimeglumine is enzymatically converted to aprepitant in plasma and tissues. This prodrug activation is predictable, ensuring consistent NK1 receptor antagonism for experimental studies. Fosaprepitant Dimeglumine’s conversion enhances solubility and facilitates handling in both in vitro and in vivo assays.

NK1 Receptor Antagonism

Upon conversion to aprepitant, Fosaprepitant Dimeglumine competitively inhibits Substance P binding, resulting in:

  • Inhibition of Gq/Gs-mediated signaling

  • Suppression of PLC/IP3-mediated calcium flux

  • Modulation of MAPK/ERK, JNK, and p38 pathways

  • Altered transcription factor activity (NF-κB, STAT, CREB)

Neuroimmune and Cytokine Modulation

Fosaprepitant Dimeglumine reduces NK1 receptor-mediated cytokine release, including IL-1β, IL-6, and TNF-α, affecting microglial and astrocyte activation and neurogenic inflammatory processes. Its use allows researchers to probe the influence of NK1 receptor antagonism on oxidative stress and neuroimmune signaling.

GPCR Signal Modulation

Fosaprepitant Dimeglumine and its active metabolite aprepitant influence:

  • β-arrestin recruitment and receptor internalization

  • cAMP/PKA signaling cascades

  • Regulation of stress-responsive transcriptional programs

Preclinical Research Applications

Fosaprepitant Dimeglumine is used for:

  • NK1 receptor desensitization studies

  • Ligand-receptor binding and kinetics assays

  • Cytokine profiling and neuroimmune modulation

  • Oxidative stress and intracellular signaling studies

  • Pharmacokinetic and pharmacodynamic modeling in preclinical animal studies

Fosaprepitant Dimeglumine’s lyophilized form ensures batch-to-batch reproducibility, stability, and accurate dosing for complex preclinical studies.

fosaprepitant-dimeglumine-cas-265121-04-8-images


Side Effects (Preclinical Observations)

Cellular Effects

  • Reduced Substance P-mediated calcium flux

  • Modulated cytokine secretion patterns

  • Suppression of neurogenic inflammatory pathways

Biochemical Effects

  • Altered MAPK/ERK, JNK, and p38 signaling

  • Regulation of transcription factor activity (NF-κB, STAT, CREB)

  • Effects on oxidative stress signaling and apoptosis pathways

Handling Considerations

  • Use appropriate PPE and work in a fume hood

  • Store lyophilized Fosaprepitant Dimeglumine at 2–8 °C, protect from light and moisture

  • Strictly for laboratory research; not for human or veterinary use


Keywords

Fosaprepitant Dimeglumine, NK1 receptor antagonist, Substance P inhibitor, prodrug of aprepitant, neurokinin signaling research, cytokine modulation, GPCR biology, receptor-ligand kinetics, high-purity research chemical, factory small-molecule supplier, China chemical manufacturer, OEM & bulk production, laboratory research reagent


Shipping Guarantee

All shipments of Fosaprepitant Dimeglumine powder are handled using validated cold-chain logistics. Lyophilized powder is protected with moisture-proof and insulated packaging, shipped via express international couriers with full tracking and insurance.


Trade Assurance

Product authenticity is guaranteed. ≥99% purity verified by HPLC, MS, and NMR. CoA provided for every batch. Refund or replacement is available for any deviation from specifications.


Payment Support

Global payment options include PayPal, Visa, MasterCard, American Express, T/T, USDT, Bitcoin, and Ethereum. All transactions are encrypted and verified.


Disclaimer

Fosaprepitant Dimeglumine is for laboratory research only. Not for human or veterinary use. Researchers must adhere to institutional safety protocols.


References

Additional information

Weight1.1 kg
Dimensions18 × 16 × 18 cm

Reviews

There are no reviews yet.

Be the first to review “Fosaprepitant Dimeglumine | CAS 265121-04-8 | NK1 Receptor Antagonist Prodrug for Neurokinin Pathway Research”

Your email address will not be published. Required fields are marked *

What is Fosaprepitant Dimeglumine used for in laboratory research?

Fosaprepitant Dimeglumine is a high-purity NK1 receptor antagonist prodrug used to study neurokinin signaling, cytokine modulation, GPCR pathways, and receptor-mediated intracellular signaling in preclinical molecular and cellular assays.

How is Fosaprepitant Dimeglumine converted to aprepitant?

Fosaprepitant Dimeglumine is enzymatically dephosphorylated in plasma and tissues to release aprepitant, which competitively inhibits Substance P binding to NK1 receptors, enabling precise pharmacological studies.

What is the purity of Fosaprepitant Dimeglumine supplied?

All batches of Fosaprepitant Dimeglumine are verified ≥99% purity by HPLC, MS, and NMR analyses to ensure consistency and reproducibility in preclinical research.

How should Fosaprepitant Dimeglumine lyophilized powder be stored?

Store at 2–8 °C, protected from light and moisture. Avoid repeated freeze-thaw cycles after reconstitution to maintain chemical stability.

Which solvents are suitable for reconstituting Fosaprepitant Dimeglumine?

Fosaprepitant Dimeglumine is soluble in water, DMSO, and selected laboratory-grade aqueous buffers, allowing flexible preparation for in vitro or in vivo assays.

Can Fosaprepitant Dimeglumine be used for GPCR signaling studies?

Yes, Fosaprepitant Dimeglumine (via aprepitant) blocks NK1 receptor GPCR signaling, regulating intracellular calcium, MAPK/ERK, JNK, and p38 pathways for mechanistic studies.

Is Fosaprepitant Dimeglumine suitable for cytokine modulation research?

Yes, preclinical studies show Fosaprepitant Dimeglumine inhibits NK1 receptor-mediated cytokine release, including IL-1β, IL-6, and TNF-α, useful for neuroimmune and inflammatory assays.

Can Fosaprepitant Dimeglumine be used in neuroinflammation models?

Yes, Fosaprepitant Dimeglumine is widely applied in vitro and in vivo to investigate NK1 receptor blockade effects on neuroinflammation, oxidative stress, and neuronal signaling.

Is bulk or OEM production of Fosaprepitant Dimeglumine available?

Yes, Fosaprepitant Dimeglumine is supplied by verified chemical manufacturers with OEM and bulk production options for preclinical laboratories.

What safety precautions are required when handling Fosaprepitant Dimeglumine?

Use appropriate PPE, including gloves and lab coats, work in a fume hood, and follow institutional safety protocols. The compound is strictly for research use only.

Can Fosaprepitant Dimeglumine be used in receptor-ligand binding assays?

Yes, Fosaprepitant Dimeglumine is ideal for NK1 receptor binding kinetics and ligand competition studies after conversion to aprepitant.

Which analytical methods confirm Fosaprepitant Dimeglumine quality?

Quality is confirmed using HPLC, MS, and NMR, with each batch supplied with a Certificate of Analysis (CoA) for verification.

Can Fosaprepitant Dimeglumine be used in in vivo preclinical models?

Yes, Fosaprepitant Dimeglumine’s water-soluble lyophilized form allows accurate dosing in animal models to study NK1 receptor antagonism, cytokine modulation, and neurokinin signaling.

Are high-purity Fosaprepitant Dimeglumine powders available?

Yes, all batches meet ≥99% purity standards, ensuring reliable results in preclinical pharmacological studies.

What research applications are suitable for Fosaprepitant Dimeglumine?

Fosaprepitant Dimeglumine is suitable for NK1 receptor studies, GPCR signaling, neuroimmune modulation, cytokine profiling, oxidative stress assays, receptor-ligand kinetics, and preclinical pharmacokinetic/pharmacodynamic investigations.


EMI Options